Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury

Clinical trial NCT04397510 · TERMINATED

Trial details

NCT number: NCT04397510
Sponsor: Frederick Health
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Covid-19 ARDS, Human Acute Lung Injury

Start date: 2020-06-01
Primary completion: 2021-12-31
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.